We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+19.83%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.32B
AUM Growth
+$1.51B
Cap. Flow
+$1.01B
Cap. Flow %
18.97%
Top 10 Hldgs %
41.92%
Holding
164
New
62
Increased
26
Reduced
36
Closed
37

Top Buys

Rank Stock Value
1
RUN icon
Sunrun
RUN
+$145M
2
META icon
Meta Platforms (Facebook)
META
+$135M
3
COF icon
Capital One
COF
+$126M
4
NFLX icon
Netflix
NFLX
+$124M
5
BILL icon
BILL Holdings
BILL
+$115M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$143M
2
MA icon
Mastercard
MA
+$97.9M
3
CRM icon
Salesforce
CRM
+$83.6M
4
DD icon
DuPont de Nemours
DD
+$75.9M
5
UNH icon
UnitedHealth
UNH
+$73.4M

Sector Composition

Rank Sector Weight
1 Technology 33.16%
2 Consumer Discretionary 11.55%
3 Communication Services 9.21%
4 Healthcare 7.22%
5 Financials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
101
Zimmer Biomet
ZBH
$18.6B
$3.87M 0.07%
25,853
-11,227
-30% -$1.59M
BMY icon
102
CALL
Bristol-Myers Squibb
BMY
$130B
$3.1M 0.06%
+50,000
New +$3.07M
FE icon
103
FirstEnergy
FE
$29B
$3M 0.06%
+97,874
New +$2.93M
ISRG icon
104
Intuitive Surgical
ISRG
$127B
$2.82M 0.05%
10,356
-744
-7% -$185K
CHE icon
105
Chemed
CHE
$7.14B
$2.81M 0.05%
5,275
+3,000
+132% +$1.47M
OSH
106
DELISTED
Oak Street Health, Inc.
OSH
$2.69M 0.05%
44,000
-228,430
-84% -$12M
OMCL icon
107
Omnicell
OMCL
$1.96B
$2.64M 0.05%
+22,000
New +$2.16M
CHTR icon
108
Charter Communications
CHTR
$17.1B
$2.38M 0.04%
+3,605
New +$2.29M
BHVN
109
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.23M 0.04%
+26,000
New +$2.2M
IMVT icon
110
Immunovant
IMVT
$7.81B
$2.16M 0.04%
+46,700
New +$2.16M
BIIB icon
111
Biogen
BIIB
$31B
$2.08M 0.04%
+8,500
New +$2.19M
HZNP
112
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.92M 0.04%
+26,250
New +$1.95M
PFE icon
113
CALL
Pfizer
PFE
$144B
$1.84M 0.03%
+50,000
New +$1.83M
IQV icon
114
IQVIA
IQV
$40.3B
$1.79M 0.03%
+10,000
New +$1.69M
THC icon
115
Tenet Healthcare
THC
$22.3B
$1.62M 0.03%
40,494
+10,094
+33% +$326K
MRNA icon
116
Moderna
MRNA
$21.6B
$1.57M 0.03%
15,000
– –
NVAX icon
117
Novavax
NVAX
$1.21B
$1.34M 0.03%
12,000
-3,000
-20% -$319K
AFG icon
118
American Financial Group
AFG
$12.1B
$1.32M 0.02%
+15,024
New +$1.23M
BNTX icon
119
BioNTech
BNTX
$23.4B
$1.02M 0.02%
+12,500
New +$1.23M
AVTR icon
120
Avantor
AVTR
$9.63B
$1M 0.02%
+35,651
New +$919K
NXE icon
121
NexGen Energy
NXE
$5.84B
$828K 0.02%
+300,000
New +$601K
APTV icon
122
Aptiv
APTV
$12.3B
$827K 0.02%
6,347
-184,966
-97% -$20.5M
V icon
123
Visa
V
$709B
$652K 0.01%
2,981
-314,955
-99% -$64.5M
ALT icon
124
Altimmune
ALT
$580M
$564K 0.01%
+50,000
New +$589K
EQR icon
125
Equity Residential
EQR
$25.7B
$209K ﹤0.01%
3,518
-2,270
-39% -$128K
3 4
5
6 7

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

PointState Capital's Q4 2020 Portfolio in Review

As of Q4 2020, PointState Capital held 164 positions worth $5.32B, up 40% from $3.81B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

PointState Capital deployed $1.01B of net new capital in Q4 2020, opening 62 new positions and adding to 26 existing holdings. Its largest new stake was Sunrun: 2,339,797 shares worth $162M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Booking.com, an estimated $143M trimmed.

  • PointState Capital's largest Q4 2020 buy was Sunrun: 2,339,797 shares worth $162M.
  • PointState Capital added most to Capital One in Q4 2020, an estimated $126M increase.
  • PointState Capital's biggest Q4 2020 reduction was Booking.com, cutting an estimated $143M.
  • PointState Capital fully exited DuPont de Nemours in Q4 2020, selling an estimated $75.9M.
  • PointState Capital's ten largest holdings make up 42% of its $5.32B portfolio in Q4 2020.
  • PointState Capital opened 62 new positions and closed 37 in Q4 2020.
  • PointState Capital's portfolio value rose 40% quarter-over-quarter to $5.32B.

Based on PointState Capital's 13F filing for Q4 2020, filed 16 Feb 2021.